Risk of type 2 diabetes in patients with nonalcoholic fatty liver disease: Causal association or epiphenomenon?

被引：0
|
作者：
Targher, G. [1 ]
Marchesini, G.
Byrne, C. D.
机构：
[1] Univ Verona, Dept Med, Sect Endocrinol Diabet & Metab, Piazzale Stefani 1, I-37126 Verona, Italy
来源：
ORVOSI HETILAP | 2016年 / 157卷 / 50期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2016 / 2016
页数：1
相关论文
共 50 条
  • [31] The Determinants of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
    Dai, Chia-Yen
    Fang, Tzu-Jung
    Hung, Wei-Wen
    Tsai, Hui-Ju
    Tsai, Yi-Chun
    BIOMEDICINES, 2022, 10 (07)
  • [32] The Global Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among Patients With Type 2 Diabetes
    Younossi, Zobair M.
    Golabi, Pegah
    Price, Jillian Kallman
    Owrangi, Soroor
    Gundu-Rao, Nagashree
    Satchi, Romona
    Paik, James M.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (10) : 1999 - 2010
  • [33] IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
    Bian, Hua
    Zhu, Xiaopeng
    Xia, Mingfeng
    Yan, Hongmei
    Chang, Xinxia
    Hu, Xiqi
    Pan, Baishen
    Guo, Wei
    Li, Xiaoying
    Gao, Xin
    ENDOCRINE PRACTICE, 2020, 26 (04) : 444 - 453
  • [34] Fibrosis Risk in Nonalcoholic Fatty Liver Disease Is Related to Chronic Kidney Disease in Older Type 2 Diabetes Patients
    Sun, Yifan
    Hong, Liang
    Huang, Zhe
    Wang, Lihong
    Xiong, Yanqin
    Zong, Shuhang
    Zhang, Rui
    Liu, Jun
    Zang, Shufei
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (09): : E3661 - E3669
  • [35] Association of serum vitamin D level and type 2 diabetes with nonalcoholic fatty liver disease
    Lee, Maosheng
    Peng, Siping
    Xiao, Xiaohui
    Li, Zengying
    Zhao, Hengxia
    Li, Huilin
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 153
  • [36] Nonalcoholic Fatty Liver Disease Is an Independent Risk Factor for Macrovascular and Microvascular Complications in Patients with Type 2 Diabetes
    Zhang, Lei
    Wang, Na
    Wang, Jun
    Yin, Xiaoyan
    Yang, Yuxiu
    Gao, Weiguo
    Dong, Yanhu
    DIABETES, 2019, 68
  • [37] Safety and effectiveness of rosiglitazone in type 2 diabetes patients with nonalcoholic fatty liver disease
    Wang, Chao-Hung
    Leung, Ching-Hsiang
    Liu, Sung-Chen
    Chung, Cheng-Ho
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2006, 105 (09) : 743 - 752
  • [38] Characteristics of Patients with Type 2 Diabetes without Nonalcoholic Fatty Liver Disease (NAFLD)
    Saenz, Enrique Valdez
    Leiva, Eddison Godinez
    Lomonaco, Romina
    Marangi, Stephen A.
    Kalavalapalli, Srilaxmi
    Gonzalez, Maria A.
    Chi, Xiaofei
    Rocha, Andrea Ortiz
    Mohseni, Yasmine
    Barb, Diana
    Gurka, Matthew J.
    Sharma, Anu
    Cusi, Kenneth
    DIABETES, 2023, 72
  • [39] Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Screening, Diagnosis, and Treatment
    Ciardullo, Stefano
    Vergani, Michela
    Perseghin, Gianluca
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (17)
  • [40] Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes Mellitus
    Paola Portillo-Sanchez
    Kenneth Cusi
    Clinical Diabetes and Endocrinology, 2 (1):
12345